Insiders · Profile

Zanganeh Mahkam

Co-Chief Executive Officer at Summit Therapeutics · Director at PULSE BIOSCIENCES. Filing since 15 Feb 2017. CIK 0001507650

Company
Date
Role
Action
Shares
Amount
Of holding
12 Jun 2026
Co-Chief Executive Officer
Bought
3,810,000
$49.99M
0.7%
4 Jun 2026
Co-Chief Executive Officer
Bought
100,000
$1.46M
0.4%
21 Oct 2025
Co-Chief Executive Officer
Bought
26,680
$499.98K
53.4%
11 Sep 2025
Co-Chief Executive Officer
Bought
5,000
$90.35K
0.0%
10 Sep 2025
Co-Chief Executive Officer
Bought
333,394
$5.89M
0.1%
27 Mar 2024
Chief Executive Officer
Bought
54,321
$201.87K
0.2%
27 Mar 2024
Chief Executive Officer
Bought
26,000
$96.72K
5.3%
26 Mar 2024
Chief Executive Officer
Bought
30,000
$112.50K
opened
12 Dec 2023
Chief Executive Officer
Bought
5,000
$10.35K
1.0%
8 Mar 2023
Co-Chief Executive Officer
Bought
15,973,743
$16.77M
215%
8 Mar 2023
Co-Chief Executive Officer
Bought
7,553,301
$7.93M
324%
16 Aug 2022
Co-CEO & President
Bought
5,624,702
$5.46M
391%
16 Aug 2022
Co-CEO & President
Bought
184,430
$178.90K
105%
12 May 2021
Chief Operating Officer
Bought
389,077
$2.04M
17.3%
23 Jun 2020
Director
Bought
1,193
$12.77K
1.1%
17 Jun 2020
Director
Bought
7,950
$55.73K
8.1%
13 Dec 2017
Director
Bought
1,100
$26.38K
1.2%
12 Dec 2017
Director
Bought
1,000
$23.98K
1.1%
11 Dec 2017
Director
Bought
3,000
$68.29K
3.3%
18 Sep 2017
Director
Bought
7,775
$116.79K
2.4%
14 Sep 2017
Director
Bought
22,000
$280.88K
7.3%
3 Aug 2017
Director
Bought
15,500
$366.32K
5.4%
3 Aug 2017
Director
Bought
5,000
$115.02K
5.8%
2 Aug 2017
Director
Bought
8,290
$208.47K
3.0%
11 May 2017
Director
Bought
15,000
$312.54K
5.7%
10 May 2017
Director
Bought
5,000
$108.55K
6.2%
9 May 2017
Director
Bought
33,760
$680.50K
72.3%
20 Mar 2017
Director
Bought
5,000
$112.36K
1.9%
20 Mar 2017
Director
Bought
4,280
$98.31K
10.1%
17 Mar 2017
Director
Bought
8,960
$215.00K
26.8%
15 Feb 2017
Director
Bought
13,000
$155.65K
63.5%
31 decisions on file.